Nitroglycerin (NTG)
Class:
|
-
Organic Nitrate–Vasodilator
|
Actions:
|
-
Dilation of both arteries and veins; veins initially dilated reducing preload; higher doses dilate arterioles reducing myocardial workload and oxygen demand
-
Dilation of coronary arteries
|
Indications:
|
Chest pain
|
Pharmacokinetics:
|
-
Onset: 2 min (SL); 3 min (PO); 30 min (topical)
-
Half-Life: 5-7 minutes
-
Metabolism: Metabolized in liver
|
Adverse Effects:
|
-
Headache
-
Orthostatic hypotension
-
Reflex tachycardia
-
Flushing
-
Lightheadedness, dizziness, syncope
|
Signs of Toxicity:
|
-
Hypotension
-
Hypersensitivity (anaphylactic reaction = hives, dyspnea, itching, shock)
|
Contraindications:
|
-
Hypotension (Systolic BP < 90 mm Hg or more than 30 mm Hg below baseline)
-
Recent use of phosphodiesterase inhibitors (sildenafil [Viagra®] or vardenafil [Levitra®]) within past 24 hours
-
Recent use of phosphodiesterase inhibitor (tadalafil [Cialis®]) within past 48 hours
-
Right ventricular infarction (inferior wall MI)
|
Dosages & Routes:
|
-
PO: (sustained release tablet or capsule)
-
SL: 0.3 – 0.4 mg tablet q 5 minutes for a total of 3 doses
-
Intravenous Drip: Begin at 5 mcg/min and titrate every 3-5 minutes to therapeutic response and stable vital signs. Titrate NTG infusion until relief of chest pain or maximum of 200 mcg/min dose is achieved.
-
Topical: Transdermal patch q 24 hours for 10-12 hour duration (with at least 12 hours NTG free out of each 24 hour period)
|
Nursing Implications:
|
-
Check blood pressure and pulse before each administration of NTG–blood pressure can drop precipitously after a single dose. Hold dose if systolic BP < 90 mm Hg or more than 30 mm Hg below baseline.
-
NTG is highly unstable and should be stored in light resistant container in cool environment (not the refrigerator).
-
If SL tablets are not bitter, they have probably lost their potency.
-
Tolerance occurs during continuous administration of NTG; blood vessels do not respond as well to NTG. Therefore, patches or topical ointments are removed for 12 hours every day to reduce tolerance.
-
Acute chest pain is treated with either SL tablets or spray or with IV infusion of NTG.
-
Maintenance therapy to prevent angina is managed with topical applications or sustain-released oral medication.
-
Intravenous infusion of NTG requires special glass bottles and IV tubing (regular plastic tubing will absorb 40-80% of NTG).
-
Do not discontinue NTG intravenous infusion abruptly–it may result in precipitous rebound hypertension, angina, or coronary artery vasospasms.
-
Acetaminophen is generally given PO for relief of headache secondary to NTG therapy.
|
References:
American Heart Association. (2006). Handbook of Emergency Cardiac Care (p. 59). Salem, MA: AHA.
Dirks, J.L. (2010) Cardiovascular therapeutic management. In L.D. Urden, K.M. Stacy, & M.E. Lough's (Eds.) Critical care nursing: Diagnosis and management (6th ed., pp. 547-548). St. Louis: Mosby Elsevier.
Lehne, R.A. (2010). Pharmacology for nursing care (7th ed., pp. 583-586, 592-593). St. Louis: Saunders Elsevier.
Wilson, B.A., Shannon, M.T., Shields, K.M., & Stang, C.L. (2007). Prentice Hall Nurse's Drug Guide 2007 (pp. 1170-1174). Upper Saddle River, NJ: Pearson Prentice Hall.
Back to Cardiac Medications Front Page
Back to Hemodynamic Medications